Pages that link to "Q28272970"

The following pages link to Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients (Q28272970):

Displayed 50 items.

• Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis (Q21135220) ‎ (← links)
• MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood (Q21562182) ‎ (← links)
• Is It worth Considering Circulating microRNAs in Multiple Sclerosis? (Q26752505) ‎ (← links)
• MicroRNAs in autoimmune diseases (Q26824814) ‎ (← links)
• The genetics of multiple sclerosis: review of current and emerging candidates (Q26825782) ‎ (← links)
• miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing (Q26852074) ‎ (← links)
• MicroRNA regulation of lymphocyte tolerance and autoimmunity (Q26852975) ‎ (← links)
• MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development (Q27003271) ‎ (← links)
• Treg functional stability and its responsiveness to the microenvironment (Q27008946) ‎ (← links)
• MicroRNAs, Major Players in B Cells Homeostasis and Function (Q27010231) ‎ (← links)
• MicroRNAs as biomarkers for CNS disease (Q27013998) ‎ (← links)
• The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease (Q27015587) ‎ (← links)
• Circulating microRNAs as biomarkers for disease staging in multiple sclerosis (Q28287246) ‎ (← links)
• miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation (Q33556109) ‎ (← links)
• Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis (Q33678267) ‎ (← links)
• Expression, regulation and function of microRNAs in multiple sclerosis (Q33754662) ‎ (← links)
• Pathophysiology of translational regulation by microRNAs in multiple sclerosis (Q34174676) ‎ (← links)
• Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity (Q34233085) ‎ (← links)
• MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. (Q34244568) ‎ (← links)
• Circulating microRNAs involved in multiple sclerosis (Q34246016) ‎ (← links)
• miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization. (Q34354883) ‎ (← links)
• MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases (Q34772318) ‎ (← links)
• MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). (Q34878368) ‎ (← links)
• MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. (Q34980198) ‎ (← links)
• Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b (Q34994463) ‎ (← links)
• Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future (Q35078327) ‎ (← links)
• Genetic association and altered gene expression of mir-155 in multiple sclerosis patients (Q35669464) ‎ (← links)
• Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis (Q35828632) ‎ (← links)
• The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. (Q35930798) ‎ (← links)
• Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling (Q36082773) ‎ (← links)
• Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation (Q36101314) ‎ (← links)
• MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. (Q36127627) ‎ (← links)
• miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis (Q36139956) ‎ (← links)
• MicroRNA dysregulation in multiple sclerosis (Q36551019) ‎ (← links)
• Dicer and microRNA expression in multiple sclerosis and response to interferon therapy (Q36655150) ‎ (← links)
• Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats (Q36748227) ‎ (← links)
• Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development (Q36767522) ‎ (← links)
• MicroRNAs: The Role in Autoimmune Inflammation (Q36815415) ‎ (← links)
• Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment (Q36948933) ‎ (← links)
• MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor (Q37117838) ‎ (← links)
• MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients (Q37139127) ‎ (← links)
• Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs (Q37153957) ‎ (← links)
• Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis (Q37201031) ‎ (← links)
• Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells (Q37212300) ‎ (← links)
• Japanese Macaque Rhadinovirus Encodes a Viral MicroRNA Mimic of the miR-17 Family (Q37300464) ‎ (← links)
• A plasma microRNA signature as a biomarker for acquired aplastic anemia (Q37555805) ‎ (← links)
• Ambient particulate air pollution and microRNAs in elderly men. (Q37687776) ‎ (← links)
• MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis (Q37708294) ‎ (← links)
• Small RNA regulators of T cell-mediated autoimmunity (Q37731387) ‎ (← links)
• Multiple sclerosis etiology: beyond genes and environment (Q37742105) ‎ (← links)